We are currently building a list of upcoming conferences, including the initial ones listed below. If you would like your conference to be included in this list then please contact firstname.lastname@example.org.If you are about to present (or have recently presented) at a national or international life science or medical conference that is not currently on this list and would like to deposit your poster or slide presentation with us then please follow the simple online submission form.
September 14 - 18, 2014
20th Annual International Conference on Microbial Genomics 2014
Lake Arrowhead, CA
This conference is part of a yearly meeting initiated in 1991 to bring together genome sequencers, bioinformatics specialists, biologists, and geneticists, to forge interactions that would result in meaningful functional genomics. The goal of the meeting is to translate the influx of new genome sequencing information into useful biological studies. The Lake Arrowhead 2014 meeting will have a major focus on microbial communities, the human microbiome, pathogens, and bioenergentics. The field of genomics has reached the point where deriving the sequence of an organism’s entire genome is now seen as a beginning rather than an endpoint. The sequence itself is a powerful tool to guide further studies to achieve an understanding of the organism’s biology. This understanding requires either a detailed genetic analysis, or more rapid methods for developing functional genomics. Therefore, this years meeting will cover micro-organisms for which extensive analyses exist, and those for which new biological and technical strategies are being developed. The focus on biodiversity, the human microbiome, pathogenic organisms, and bioenergentics adds special significance to this meeting. This meeting is designed to have a mix of invited presentations and poster sessions. The meeting will have approximately 110 participants.
September 18 - 21, 2014
Society for Research in Psychopathology Meeting 2014
Evanston, IL, USA
The Society for Research in Psychopathology (SRP) is an organization of established psychopathology researchers. The Society holds an annual meeting each Fall that provides a forum for presentation and discussion of current psychopathology research. The meeting includes symposia, paper sessions, invited speakers, and poster presentations, and many opportunities for collegial discussion. Members, their graduate students, and interested colleagues attend.
September 21 - 24, 2014
12th Symposium on Bioinformatics (XII Jornadas de Bioinformática) 2014
Over the last decade, the jornadas have received remarkable submissions from computational groups that have led to new biological discoveries. With the aim of encouraging the participation of younger bioinformaticians, this year symposium's main theme is “Bioinformatics: The New Breed”.
September 26, 2014
The New York Academy of Sciences - Early-Life Influences on Obesity: From Pre-Conception to Adolescence
New York, NY, USA
The double-burden of under- and overnutrition has grave effects on human health globally. According to the World Health Organization (2013), obesity and diabetes rates have almost doubled since 1980 worldwide and more than 40 million children under 5 were overweight in 2011. Factors such as maternal nutrition, paternal genetic contributions, and the intrauterine environment play a role in diabesity. This conference will examine the roles of pre-conception and generational effects of nutrition; intrauterine environment and 'programming'; and re-setting the program after birth in development of chronic disease later in life. Global experts from the fields of maternal nutrition, obesity, the microbiome, metabolic disorders, and fetal development will discuss factors affecting obesity rat.
September 26 - 28, 2014
4th “Performing Arts Medicine” International CEIMArs Convention 2014
With support from F1000Posters, CEIMArs is pleased to announce the program for the 4th Edition of the International Performing Arts Medicine Convention led by the honorary committee: Emma Dante, Simone Ferraresi, Paola Folli and Marcello Giordani. Specifically suggested for participation are doctors, physiotherapists, speech and voice pathologists, psychologists, bioengineers, actors, dubbers, dancers, singers, musicians, circus performers etc., this event presents both theoretical and practical lectures and workshops, original and unpublished research on medicine and theatre, stage science and humanities.
September 30, 2014
The New York Academy of Sciences 2014: Elucidating GPCR Functional Selectivity: Novel Opportunities for Drug Development
New York, NY, USA
G protein-coupled receptors (GPCRs), the single largest class of druggable targets in therapeutic drug discovery, signal via canonical pathways involving heterotrimeric G proteins, and also via G protein–independent interactions with other signaling proteins, including β-arrestins, a process known as functional selectivity. Discovering ligands with the desired signaling bias at GPCRs will yield molecules with novel activities, and could lead to significantly improved therapeutics by enabling beneficial efficacy while reducing undesirable adverse effects. This symposium examines perspectives from academic and industrial scientists, highlighting basic and translational research. Researchers will discuss molecular and structural mechanisms underlying ligand bias and demonstrate how they quantify, design and develop functionally selective GPCR ligands for potential use in cardiovascular and central nervous system diseases.
October 9, 2014
The New York Academy of Sciences 2014 - Targeting Key Vulnerabilities in Pancreatic Cancer
Conference abstract submission - deadline 09 December 2014
New York, NY, USA
Pancreatic ductal adenocarcinoma remains one of the most challenging problems in oncology, with a 5-year survival rate of just 6% and few effective therapeutic options. Genomic studies have identified only four high penetrance mutations responsible for the initiation and progression of pancreatic cancer. Unfortunately, none of these alterations can currently be targeted therapeutically. Nonetheless, core signaling programs are beginning to be identified for which therapeutic approaches may be developed. Some of these programs constitute “critical dependencies” of the tumor — biological pathways on which the tumor relies for continued growth and survival — and may serve as effective therapeutic targets. These programs include metabolic alterations that take place in pancreatic tumor cells, the behavior and biology of the tumor stroma, and interactions with the host immune system. This symposium will focus on recent breakthroughs in the pathogenesis and progression of pancreatic cancer, and efforts to exploit these key vulnerabilities as the basis for novel therapeutic interventions.
October 9 - 12, 2014
39th Symposium on Hormones and Cell Regulation 2014
Mont Ste Odile, France
"Inositol lipid signaling: from molecular mechanisms to human pathologies": Phosphoinositides and inositol phosphates interact with and modulate the recruitment and activation of key regulatory proteins and in doing so control diverse functions including cell growth, proliferation and movement, apoptosis, cytoskeletal dynamics, insulin action, vesicle trafficking and nuclear functions. Controlling the levels of inositol signalling molecules and their subcellular compartmentalization is likely to be critical. This meeting will bring together scientists from different backgrounds to discuss how understanding inositol signaling may be used to target human diseases like cancer and heart diseases that manifest themselves when inositol signalling is deregulated.
October 10, 2014
The New York Academy of Sciences 2014: New Frontiers in the Neurobiology of Mental Illness
New York, NY, USA
One in four Americans suffers from mental illness such as schizophrenia, depression, fear and anxiety disorders, autism, and other psychiatric disorders. These numbers pose an enormous socioeconomic burden: adult suicide rates are rising steadily; many at-risk mentally ill patients experience homelessness and incarceration rather than hospitalization; and global costs of mental illness—which often affect otherwise healthy, working-age adults—are estimated to exceed US$16 trillion by 2030. Today, prevention and better treatment of mental illness may finally be within reach due to recent breakthroughs in neuroscience—vastly improving our understanding of the genetic, epigenetic, molecular, and cellular mechanisms; structure; and neuronal circuitry underlying normal and pathological brain function. This conference will explore the translation of these findings into pharmacological, psychotherapeutic, and other interventions to improve mental health. A keynote lecture by The Honorable Patrick J. Kennedy will address strategies to simultaneously abolish the stigma surrounding mental illness in order to fully realize the new treatments’ potential. Free Symposium. Advance registration required.
October 15 - 17, 2014
International Experimental Biology and Medicine Conference 2014
San Diego, CA, USA
ith the goal of translating the globalization of EBM to a worldwide membership for SEBM, the SEBM Council approved the opening of an SEBM/EBM China Outreach Office. With 50% of the EBM manuscripts coming from China, and the tremendous expansion of biomedical research in that country, it was the logical first location for an SEBM/EBM Outreach Office. One of the goals of the SEBM/EBM ChinaOutreach office are to increase the profile of SEBM and EBM in China and to meet this goal, a jointly planned annual international conference was held in Shanghai in 2013. Following our inaugural event in 2013, the 2014 IEBMC will be a three day conference again held at the Purple Mountain Hotel in Shanghai China on October 15th to 17th. The focus of the 2014 IEBMC will be “Stem Cell Biology and Human Diseases.” The EBM Associate Editor for Stem Cell Biology, Jian Feng, is co-Chairing the 2014 IEBMC Scientific Planning Committee with Wei-Qiang Gao serving as the other co-Chair. ;There will be workshops for students and post doctoral fellows on “How to Publish Your Manuscript” and on “Career Development”.
October 20 - 24, 2014
40th Annual Meeting of the American Society for Histocompatibility & Immunogenetics 2014
Denver, CO, USA
The 40th American Society for Histocompatibility & Immunogenetics (ASHI) Annual Meeting will provide participants with comprehensive state-of-the-art updates and glimpses into the future on a variety of topics related to the fields of genomics, immunogenetics, immunology, histocompatibility and transplantation
October 28, 2014
The New York Academy of Sciences 2014: Pharmacologic Resolution of Inflammation as a Novel Therapeutic Approach
New York City, USA
Uncontrolled, chronic inflammation is now considered a major component of many widespread diseases, which are now well-recognized as 'inflammatory diseases.' These include arthritis, asthma, atherosclerosis and peripheral vascular disease, Alzheimer’s disease, periodontal disease and cancer. There is general agreement that inflammation is not likely to be the causative factor in these diseases, but that it plays a key role in disease progression, tissue dysfunction and ultimately organ failure. In recent years, evidence has emerged that resolution of inflammation is a biochemically active process driven by multiple chemical mediators. Elucidation of the biochemical pathways contributing to the resolution of inflammation has provided many new anti-inflammatory targets and an opportunity for resolution-based pharmacology for treatment and prevention of inflammatory diseases. This symposium reviews recent discoveries and advances in the field, and demonstrates how this work translates into new approaches and new pharmacology to treat old diseases.
November 3, 2014
The New York Academy of Sciences 2014 - Gene Network Changes in Alzheimer’s Disease: Potential Points for Therapeutic Intervention
Conference abstract submission - deadline 26 September 2014
New York, NY, USA
Microglia, the resident innate immune cells of the central nervous system (CNS), have emerged as critical players in normal CNS function as well as in the progression of major disorders such as Alzheimer’s disease (AD). Although microglia have been traditionally categorized into either the pro-inflammatory ‘M1’ or the anti-inflammatory ‘M2’ phenotype, recent studies have uncovered a previously unappreciated spectrum of microglial phenotypes involved in a range of important processes including synaptic homeostasis and neurotrophic support. In order to address whether this spectrum is altered in AD, it is first necessary to elucidate the molecular signatures underlying these microglial phenotypes. Recent efforts have therefore applied next generation sequencing techniques and approaches such as weighted gene co-expression network analysis, a systems biology method for describing the correlation patterns among genes, to better understand these signatures at the genomic level. Remarkably, the most perturbed gene networks identified in AD brains fall squarely within microglial pathways and these findings are consistent with previous genome wide association studies linking specific microglial genes to AD risk. Furthermore, parallel work examining the peripheral immune system indicates that monocytes may exhibit some of the same gene network changes, opening the possibility of developing new peripheral biomarkers. This symposium will therefore focus on the identification of microglial gene network signatures associated with AD, how these phenotypes might be modulated to alter the course of AD pathology, and how a better understanding of peripheral immune biology may lead to the development of therapeutics and peripheral biomarkers for AD.
November 6, 2014
The New York Academy of Sciences 2014 - Food Safety Considerations for Innovative Nutrition Solutions
New York, NY, USA
Nutritious, abundantly available food is something that many take for granted. When food is plentiful, the choice of selecting foods from a local supplier or limiting purchases to food produced using an acceptable level of organic production methods or minimal processing becomes the norm. However, predictions of significant world population growth in the near future may profoundly affect how food is viewed. The luxury of selecting food for acceptable production methods or locality is likely to be replaced with concerns regarding availability and preventing waste. How does food safety fit into a changing landscape for food security in the future? How can waste be eliminated, yet prevent an increase in overall foodborne disease? The food safety concerns of the future are expected to undergo parallel evolution as priorities shift to finding enough food. This conference will seek to address those issues through the thoughts and predictions of internationally acclaimed experts as we prepare for the food safety issues of the future.
November 6 - 9, 2014
Society for Immunotherapy of Cancer (SITC) Meeting 2014
National Harbor, MD
Known as the premier destination for scientific exchange, education and networking in the cancer immunotherapy community, attendees will be a part of more than 1,100 anticipated basic, clinical and translational scientists from academia, government and industry, along with other top medical professionals from around the world, all dedicated to improving cancer patient outcomes through cancer immunotherapy. The SITC 2014 experience includes cutting-edge research and timely educational sessions that serve as catalysts for advancing the field - all in a personal and friendly environment that bridges the bench to bedside gap between translational research, development and clinical practice.
November 11 - 13, 2014
The New York Academy of Sciences 2014: Shaping the Developing Brain: Prenatal through Early Childhood
Conference abstract submission - deadline passed
New York City, USA
The future success of a child is crucially dependent upon the earliest stages of brain development, during pregnancy and infancy. Scientific research from multiple academic and medical disciplines has shown that the changes that take place during this early period of brain development can profoundly shape the rest of a child's life, and affect long-term health, well-being, and cognitive ability. As a child grows — from inside the womb through the first few years of life — massive changes take place in the connectivity and plasticity of the brain. Deepening our understanding of the connection between a child’s early behavioral milestones and their brain’s structural and neural development is a critical first step for promoting healthy brain development, as well as improving treatments for developmental and learning disorders. Additionally, functional or dysfunctional social and family relationships, socioeconomic status/poverty, stress, nutrition, and other environmental experiences produce lasting effects on the brain and impact how children will respond to adversity, how they will interact with their peers, and whether they will succeed in school and throughout their lives. This 2.5-day conference will convene leading researchers with expertise in the fundamental stages of early brain development, and will focus on the connection between research and improved outcomes for children. Conference speakers will present the latest discoveries from cognitive neuroscience and experimental psychology regarding typical and atypical development of human learning and memory, emotion, and social behavior in the first few years of life. They will also explore socioeconomic, family, and nutritional factors that can affect brain and behavior. The conference will highlight educational practices, health and nutrition practices, applied research, and government policy with the potential for enhancing healthy brain development and improving outcomes for at-risk children. This conference will feature a dedicated session: Spotlight on Nutrition and Brain Development, co-presented with The Sackler Institute for Nutrition Science, a program of the New York Academy of Sciences.
December 1 - 4, 2014
British Society of Immunology Annual Meeting 2014
The British Society for Immunology Congress is the BSI’s flagship event. As one of the oldest and most active immunology societies in the world, the BSI annual congress has established itself as the must attend immunology event of the year, where leading immunology specialists from all over the world come together under one roof. The congress enables the exchange of ideas and knowledge to facilitate research and collaborations focusing on immunology. For 2014 the BSI Committee is delighted to be holding the Congress at the Brighton Centre, which is regarded as one of the finest venues in the country, offering top class conference facilities to organisers and delegates alike.
December 5 - 7, 2014
25th International Symposium on Amyotrophic Lateral Sclerosis and Motor Neurone Disease 2014
Our International Symposium is the largest medical and scientific conference on MND/ALS. It is the premier event in the MND research calendar, attracting over 800 delegates, representing the energy and dynamism of the global MND research community.
December 8 - 9, 2014
9th BENELUX Bioinformatics Conference 2014
Luxembourg City, Luxembourg
BBC 2014 is the second edition of the Benelux Bioinformatics Conference that will be held in Luxembourg. The conference program will include oral presentations from all fields of bioinformatics, a poster session, talks by international speakers and a network discussion. The conference will create also opportunity for sponsors, who might present software demos and commercial products. Each BBC conference attracts up to 200 researches from both academic and public research institutions as well as from private sector. The multi-environmental and interdisciplinary character of the conference allows sharing various ideas among participants interested in fundamental biological research, biotechnologies and computational biology. Topics discussed during the BBC conferences, include, among others, research on biological networks, structural bioinformatics, and the analysis of high-throughput sequencing data and micro-array expression data. We are looking forward to meeting you in Luxembourg!
December 9, 2014
New York Academy of Sciences 2014 - Diabetic Kidney Disease: Drug Discovery and Clinical Development Challenges
Conference abstract submission - deadline 31 October 2014
New York, NY, USA
Diabetic nephropathy is the leading cause of end-stage renal disease (ESRD) in the United States, and is associated with elevated cardiovascular morbidity and mortality. The progression of kidney disease in patients with diabetes occurs over many years, and interventions such as glycemic control and blood pressure lowering with inhibitors of the renin-angiotensin-aldosterone system have been shown to slow this progression. Despite the standard of care, the prevalence of patients with ESRD secondary to diabetic nephropathy continues to rise. Recently, several drugs in late clinical development have failed due to lack of efficacy and/or safety concerns. Finding and validating new targets to treat this condition have proven challenging due to lack of a deep understanding of the pathogenesis of diabetic nephropathy and biomarkers that can reliably define the rate of kidney function loss. This symposium reviews recent experimental approaches that may lead to the identification of targets for preventive or therapeutic interventions, and discusses the current challenges in the clinical development of therapeutic agents to treat diabetic kidney disease.